Data from experimental and clinical studies demonstrate a link between various pro-inflammatory pathways, including TLR, RIG-I, CLRs, STING signaling and inflammasomes, and the pathogenesis of glomerular diseases of metabolic, non-metabolic or genetic origins (Figure 1). This evidence concerns the gene STING1 and glomerular disorder.